메뉴 건너뛰기




Volumn 2, Issue 9, 2001, Pages 1473-1477

Zinc acetate for the treatment of Wilson's disease

Author keywords

Blockade of copper absorption; Copper toxicity; Galzin ; Metallothionein induction; Wilson's disease; Zinc

Indexed keywords

COPPER; METALLOTHIONEIN; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC ACETATE;

EID: 0034845675     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.9.1473     Document Type: Article
Times cited : (95)

References (30)
  • 3
    • 0034109410 scopus 로고    scopus 로고
    • Recognition, diagnosis and management of Wilson's disease
    • (2000) PSEBM , vol.223 , Issue.1 , pp. 39-49
    • Brewer, G.J.1
  • 5
    • 0003628404 scopus 로고    scopus 로고
    • Wilson's disease: A Clinician's Guide to Recognition, Diagnosis, and Management
    • Kluwer Academic Publishers, Boston, USA
    • (2001)
    • Brewer, G.J.1
  • 8
  • 9
    • 0020086199 scopus 로고
    • Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride
    • (1982) Lancet , vol.1 , pp. 643-647
    • Walshe, J.M.1
  • 30
    • 0003813337 scopus 로고
    • Teratologic evaluation of FDA 71-49 (zinc sulfate)
    • Food and Drug Administration: Food and Drug Research Laboratories, Inc. Prepared for Food and Drug Administration, United States Department of Commerce Publications PD-221 805. February 1973, and PB 267, June
    • (1974)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.